Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Procalcitonin: A useful biomarker to discriminate infection after cardiopulmonary bypass in children

Garcia, Iolanda Jordan PhD; Gargallo, Mònica B. MD; Torné, Elisabeth E. MD; Lasaosa, Francisco José Cambra PhD; Viñas, Anna T. MD; Tolosa, Carme V. PhD; Rico, Antonio P. PhD

Pediatric Critical Care Medicine: July 2012 - Volume 13 - Issue 4 - p 441–445
doi: 10.1097/PCC.0b013e31823890de
Cardiac Intensive Care
Buy

Objective: To determine whether procalcitonin discriminates between postcardiopulmonary bypass inflammatory syndrome and infectious complication in children better than does C-reactive protein.

Design: Prospective study of children admitted to the intensive care unit after cardiopulmonary bypass.

Patients: Classified according to a diagnosis of systemic inflammatory response syndrome and bacterial infection or systemic inflammatory response syndrome but no bacterial infection. Two hundred thirty-one cases were recruited.

Measurement and Main Results: Procalcitonin, C-reactive protein, and leukocyte count were measured daily from surgery until day 3. Twenty-two patients were infected (9.5%). Significant differences were detected in the procalcitonin values of the infected group vs. the noninfected group, especially at day 2 (p = .000). There were no differences in the C-reactive protein values. The optimal cutoff for procalcitonin was >2 ng/mL at day 1 and above 4 ng/mL at the day 2. There was a greater sensitivity and specificity than with C-reactive protein as an infection predictor.

Conclusion: Procalcitonin is useful in the diagnosis of bacterial infection after cardiopulmonary bypass. Because procalcitonin kinetics are different in postcardiopulmonary bypass patients, the cutoff to diagnose infection should be different from the normal cutoff.

From the Pediatric Intensive Care Unit Service (IJG, MBG, EET, FJCL, APR), Pediatric Service (ATV), and Hormonal Laboratory Service (CVT), Hospital de Sant Joan de Déu, Barcelona, Spain.

The authors have not disclosed any potential conflicts of interest.

For information regarding this article, E-mail: ijordan@hsjdbcn.org

©2012The Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies